The US FDA Accelerated Approval of sotorasib required the sponsor to conduct a randomized trial that compared the safety and efficacy of the approved dose with a lower dose. These results, recently disclosed, have important implications for patients, payers, oncologists and the pharmaceutical industr...
Aki Tsukioka
SEOUL, South Korea,Sept. 29, 2020/PRNewswire/ -- Daewoong Pharmaceutical (Daewoong) (CEOSengho Jeon) announced the result of its phase 2 trial on enavogliflozin, a novel SGLT2 inhibitor, for the first time at the 2020 Internation...
•药品(PharmaceuticalProduct):指用 于预防、治疗、诊断人的疾病,有目的地调 节人体生理机能并规定有适应证、用法和用 量的物质。 •试验用药品(InvestigationalProduct): 临床试验中用作试验或参比的任何药品或安 慰剂。 兀溆跺贾薛恺荀雍氏畀怜预喇优鲵褶瑕酪淮衲钨配役炉迁挖造晾青斤负瘫垸鲩呙萸时矽...
2 S.M. Paul, D.S. Myteka, C.T. Dunwiddie, et al. How to improve R&D productivity: the pharmaceutical industry’s grand challenge Nature Rev Drug Dis, 9 (2010), pp. 203-214 CrossrefView in ScopusGoogle Scholar 3 G. Van Norman Drugs, Devices and the FDA: Part 1. An overview ...
Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cell and medical technology. Diamyd Medical develops the diabetes vaccine Diamyd®, for antigen-specific immunotherapy based on the exclusively licens...
The first patient has been dosed in the multi-regional, global, phase 2 clinical trial (NCT05178043) of the combination therapy, ALK-1 antibody (GT90001) and nivolumab (Opdivo), for the treatment of patients with advanced hepatocellular carcinoma (HCC), according to Kintor Pharmaceu...
VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, is pleased to announce the topline results from the ACcomplisH China Phase 2 Trial in children with achondroplasia (ACH) aged 2 to 10 years.
近日,国内AI制药独角兽之一的英矽智能在《自然-生物技术》杂志发表研究论文,揭示了公司使用人工智能开发的用于治疗特发性肺纤维化的TNIK抑制剂,从靶点发现到临床II期的研发全过程,并首度披露该款AI药物的临床前和临床试验数据。Recently, Insilico Medicine, one of the AI pharmaceutical unicorns in China, published...
Berg Pharma is a Boston based pharmaceutical company and parent company to Berg Biosystems and Berg Diagnostics. Our research focus seeks to understand how alterations in metabolism relate to disease onset. We have uncovered key insight into metabolic control factors and namely into underlying elements...